1Castelli W P, Anderson K,Wilson P W, at al . Lipids and risk of coronary heart diseases the Framingham Study [J]. Ann Epidemiol, 1992,2(1) : 23-28.
2Kweiterovich PO Jr. The Antiatherogenic role of highdensity lipoprotein cholesterol[J]. Am J Cardiol, 1998,82 ( 1 ): 13Q-21Q.
3Hokanson J E, Austin M A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of populationbased prospective studies[J]. J Cardiovase Res, 1996,3(2) :213-219.
4Castelli W P. Epidemiology of triglycerides: a view from Framingham[J]. Am J Cardiol, 1992,70(supple):3H-9H.
5Zoratti R. A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin?. [J]. Eur J Epidemiol,1998 ,14(1) :9-21.
6Proudler A J, Godsland I F, Bruce R, at al. Lipid and carbohydrate metabolic risk markers for coronary heart disease and blood pressure in health non-obese premenopausal women of different racial origins in the United Kingdom [J].Metabolism, 1996,45 (3) :328-333.
7Lyu L C,Shieh M J,Ordovas J M, et al . Plasma lipoprotein and apolipoprotein levels in Taipei and Framinghan[J]. Arterioscler Thromb, 1993,13 (10) s 1429-1440.
8Knapp R G,Sutherland S E, Keil J E, at al . A comparison of the effects of cholesterol on CHD mortality in black and white women., twenty-eight years of follow-up in the Charleston Heart Study[J]. J Clin Epidemiol, 1992,45 (10) :1119-1129.
